Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA2DS2‐VASc score of 0
Authors:
- Hyohun ChoiHCHyohun Choi
- Myung Hwan BaeMBMyung Hwan Bae
- Yoon Jung ParkYPYoon Jung Park
- Hyuk Kyoon ParkHPHyuk Kyoon Park
- Eunkyu LeeELEunkyu Lee
- Myeong Seop KimMKMyeong Seop Kim
- Jong Sung ParkJPJong Sung Park
- Hyeon Jeong KimHKHyeon Jeong Kim
- Bo Eun ParkBPBo Eun Park
- Hong Nyun KimHKHong Nyun Kim
- Namkyun KimNKNamkyun Kim
- Jang Hoon LeeJLJang Hoon Lee
Open Access
- 10 January 2023
- journal article
- research article
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 28 (2) , e13036
Abstract
Background: Anticoagulant therapy has been important for stroke prevention in patients with atrial fibrillation (AF). However, it was not recommended due to its relatively higher risk of bleeding than its lower risk of stroke in patients with a CHA2DS2‐VASc score of 0.Hypothesis: This study aimed to evaluate the predictors of stroke in AF patients with very low risk of stroke.Methods: Between 1990 and 2020, 542 patients with non‐valvular AF (NVAF) with a CHA2DS2‐VASc score of 0 followed up for at least 6 months were enrolled. Patients with only being woman as a risk factor were included as a CHA2DS2‐VASc score of 0 in this study. The primary outcome was stroke or systemic embolism.Results: The primary outcome rate was 0.78%/year. In Cox hazard model, age of ≥50 years at diagnosis (hazard ratio [HR] 6.710, 95% confidence interval [CI] 1.811–24.860, p = .004), LVEDD of ≥46 mm (HR 4.513, 95% CI 1.038–19.626, p = .045), and non‐paroxysmal AF (HR 5.575, 95% CI 1.621–19.175, p = .006) were identified as independent predictors of stroke or systemic embolism. Patients with all three independent predictors had a higher risk of stroke or systemic embolism (4.21%/year), whereas those without did not have a stroke or systemic embolism.Conclusion: The annual stroke or systemic embolism rate in NVAF patients with CHA2DS2‐VASc score of 0 was 0.78%/year, and age at AF diagnosis, LVEDD, and non‐paroxysmal AF were independent predictors of stroke or systemic embolism in patients considered to have a very low risk of stroke.Keywords
This publication has 26 references indexed in Scilit:
- Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc ScoreJACC, 2015
- Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF TrialEuropean Heart Journal, 2014
- Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialEuropean Heart Journal, 2013
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort studyBMJ, 2011
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest, 2010
- Diastolic dysfunction and atrial fibrillationJournal of Interventional Cardiac Electrophysiology, 2008
- Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyEuropean Heart Journal, 2006
- Avoiding Central Nervous System Bleeding During Antithrombotic TherapyStroke, 2005
- Lifetime Risk for Development of Atrial FibrillationCirculation, 2004
- Independent Risk Factors for Atrial Fibrillation in a Population-Based CohortJAMA, 1994